This inventor holds 2 USPTO granted patents. Top assignee: Orion Corporation. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: Jarmo Lintulaakso: Innovator in Pharmaceutical Composition
Introduction
Jarmo Lintulaakso is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. With a total of 2 patents, Lintulaakso's work has the potential to impact many lives.
Latest Patents
Lintulaakso's latest patents include a pharmaceutical composition comprising entacapone, levodopa, and carbidopa. This oral solid fixed dose composition contains pharmacologically effective amounts of these compounds, or their pharmaceutically acceptable salts or hydrates, along with at least one pharmaceutically acceptable excipient. The composition is designed for the treatment of Parkinson's disease, showcasing Lintulaakso's commitment to addressing critical health issues.
Career Highlights
Jarmo Lintulaakso is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on innovative solutions that enhance patient care and treatment efficacy.
Collaborations
Lintulaakso has collaborated with esteemed colleagues such as Matti Virkki and Kari Vahervuo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical development.
Conclusion
Jarmo Lintulaakso's contributions to pharmaceutical innovation, particularly in the treatment of Parkinson's disease, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile